179 related articles for article (PubMed ID: 547652)
1. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
Bolzano K; Krempler F; Schellenberg B; Schlierf G
Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
[No Abstract] [Full Text] [Related]
3. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with bezafibrate.
Schubotz R; Schneider J; Hausmann L; Mühlfellner G; Mühlfellner O; Kaffarnik H
Artery; 1980; 8(6):553-9. PubMed ID: 7259534
[TBL] [Abstract][Full Text] [Related]
5. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
[No Abstract] [Full Text] [Related]
6. [Plafibride treatment of hyperlipidemias type II and IV].
Soler J; Vinzia C; Gómez JM; Morató J
Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
[No Abstract] [Full Text] [Related]
7. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb].
Kokot F; Szczechowska E
Z Gesamte Inn Med; 1981 Jul; 36(13):454-7. PubMed ID: 7025475
[TBL] [Abstract][Full Text] [Related]
8. The effect of etofibrate retard, bezafibrate and procetofen.
Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
Artery; 1980; 8(2):128-33. PubMed ID: 7458677
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
[No Abstract] [Full Text] [Related]
10. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
Schwandt P; Weisweiler P
Artery; 1980; 7(6):464-70. PubMed ID: 7236016
[TBL] [Abstract][Full Text] [Related]
11. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Artery; 1980; 8(2):113-9. PubMed ID: 7458676
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
13. [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].
Lageder H
Wien Klin Wochenschr; 1980 Feb; 92(3):95-101. PubMed ID: 6985560
[TBL] [Abstract][Full Text] [Related]
14. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
Altomonte L; Mingrone G; Ghirlanda G; Manna R; Rebuzzi A; Pala MA; Greco AV
Minerva Med; 1980 Feb; 71(4):273-8. PubMed ID: 7354946
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effects and tolerance of etofylline clofibrate].
Ziegler WJ; Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
Sznajderman M
Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
[No Abstract] [Full Text] [Related]
17. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
Artery; 1980; 8(6):537-46. PubMed ID: 6114725
[TBL] [Abstract][Full Text] [Related]
18. Plafibride treatment and serum lipids in hyperlipoproteinemias.
Rodriguez F; López IM; Jover E
J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
[TBL] [Abstract][Full Text] [Related]
19. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil--a new lipid lowering agent.
Nash DT
J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
